Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of methylergometrine maleate injection for prevention of postpartum hemorrhage after cesarean section
CTR20244813Phase 3Active
- Sponsor
- Boyao Biopharmaceutical
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylergometrine in postpartum hemorrhage (PPH), sponsored by Boyao Biopharmaceutical. Started Jun 2025; status: active.
02
Drugs
methylergometrine
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on CTR20244813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244813.